Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Burcon NutraScience stock

BU.TO
CA1208311029
157793

Price

0.12
Today +/-
-0.00
Today %
-5.17 %
P

Burcon NutraScience stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Burcon NutraScience stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Burcon NutraScience stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Burcon NutraScience stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Burcon NutraScience's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Burcon NutraScience Stock Price History

DateBurcon NutraScience Price
11/5/20240.12 undefined
11/1/20240.13 undefined
10/31/20240.14 undefined
10/30/20240.13 undefined
10/29/20240.13 undefined
10/28/20240.14 undefined
10/25/20240.14 undefined
10/24/20240.14 undefined
10/23/20240.15 undefined
10/22/20240.15 undefined
10/21/20240.15 undefined
10/18/20240.13 undefined
10/17/20240.14 undefined
10/16/20240.15 undefined
10/15/20240.15 undefined
10/11/20240.15 undefined
10/10/20240.16 undefined
10/9/20240.16 undefined
10/8/20240.15 undefined
10/7/20240.15 undefined

Burcon NutraScience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Burcon NutraScience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Burcon NutraScience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Burcon NutraScience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Burcon NutraScience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Burcon NutraScience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Burcon NutraScience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Burcon NutraScience’s growth potential.

Burcon NutraScience Revenue, EBIT and net profit per share

DateBurcon NutraScience RevenueBurcon NutraScience EBITBurcon NutraScience Net Income
2026e9.06 M undefined515,000 undefined1.47 M undefined
2025e3.3 M undefined-4.64 M undefined-4.41 M undefined
2024184,360 undefined-7.02 M undefined-7.45 M undefined
2023360,000 undefined-7.52 M undefined-25.36 M undefined
2022170,000 undefined-7.36 M undefined-10.26 M undefined
2021260,000 undefined-4.58 M undefined-620,000 undefined
202030,000 undefined-3.63 M undefined-4.63 M undefined
201940,000 undefined-4.36 M undefined-4.78 M undefined
201850,000 undefined-5.63 M undefined-5.62 M undefined
201790,000 undefined-5.72 M undefined-5.78 M undefined
2016110,000 undefined-6.79 M undefined-6.57 M undefined
2015110,000 undefined-6.89 M undefined-6.58 M undefined
201490,000 undefined-6.25 M undefined-5.96 M undefined
201330,000 undefined-5.63 M undefined-5.55 M undefined
20120 undefined-6.1 M undefined-5.96 M undefined
20110 undefined-8.95 M undefined-8.81 M undefined
20100 undefined-7.08 M undefined-6.99 M undefined
20090 undefined-4.89 M undefined-4.81 M undefined
20080 undefined-4.27 M undefined-4.04 M undefined
20070 undefined-3.73 M undefined-3.55 M undefined
20060 undefined-2.92 M undefined-2.86 M undefined
20050 undefined-3.2 M undefined-3.15 M undefined

Burcon NutraScience Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (k)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e
0000000000000000000000000039
---------------------------200.00
----------------------------
000000000000000000-1-1-100-10000
00-2-3-3-2-3-2-3-4-4-7-8-6-5-6-6-6-5-5-4-3-4-7-7-7-40
---------------------------133.33-
00-2,000-3,000-3,000-2,000-3,000-2,000-3,000-4,000-4,000-6,000-8,000-5,000-5,000-5,000-6,000-6,000-5,000-5,000-4,000-4,0000-10,000-25,000-7,000-4,0001,000
---50.00--33.3350.00-33.3350.0033.33-50.0033.33-37.50--20.00--16.67--20.00---150.00-72.00-42.86-125.00
4.57.311.412.5714.6416.2518.621.5423.6325.0425.4628.2929.5529.9630.6231.6233.635.5836.4938.6143.9478.94102.89108.59108.73121.400
----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Burcon NutraScience Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Burcon NutraScience is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                   
0.442.142.941.050.943.571.062.516.174.222.2413.9811.936.166.691.393.672.484.73.420.4915.0313.9771.464.2
102080302020201020204030404030140150150160150130330340200330591.73
00000000000000000000000000
0000000000000000000001301300068.32
103010020307010090801801401108048015017022017018023031029015041080330.03
0.462.193.121.10.993.661.182.616.274.422.4214.1212.056.686.871.74.042.85.043.80.9315.7814.597.611.875.19
00.150.661.831.761.411.170.980.890.760.630.750.730.630.560.660.560.510.490.380.280.471.010.860.981.1
00000000000000000000012.216.413.400
0000000000000000000000001700
00000000000000000000000000
03.042.571.261.261.261.261.261.261.261.251.251.251.251.251.251.251.251.251.251.251.251.251.251.251.25
0.0300.010.020.0300.04000000.191.971.821.50.850.280001.554.466.225.85.37
0.033.193.243.113.052.672.472.242.152.021.8822.173.853.633.412.662.041.741.631.5315.4723.1221.738.27.73
0.495.386.364.214.046.333.654.858.426.444.316.1214.2210.5310.55.116.74.846.785.432.4631.2537.7129.3410.0712.91
                                                   
0.485.968.539.1510.914.6514.7818.5525.0226.2828.2744.2447.1648.0654.0154.0160.9664.947073.3673.3698.05114.11114.57114.57122.07
00001.351.352.923.693.693.693.713.763.764.015.076.146.266.496.787.699.0314.0615.8816.8917.46
-0.01-0.65-2.45-5.22-8.46-9.96-14.24-17.6-20.59-23.75-28.02-32.28-38.02-42.68-49.33-55.82-61.43-67.31-72.66-78.62-84.34-86.89-91.89-102.2-127.32-134.37
0000000000000000000002.7607.057.410
00000000000000000000000000
0.475.316.083.933.796.043.464.648.126.223.9615.7212.99.399.754.335.794.124.122.34-1.9822.9536.2835.311.555.15
0.010.070.290.280.240.280.180.20.30.220.350.41.330.920.450.570.710.70.520.80.631.071.420.910.590.84
000000000000000000005602500100
0000000000000000700200601028001200250
000000000000000000001.2500000
000000000000000000001.9900.030.010.030.26
0.010.070.290.280.240.280.180.20.30.220.350.41.330.920.450.570.780.70.720.864.441.61.451.040.621.35
0000000000000000001.821.9106.730.010.065.146.4
00000000000000000000000000
000000000000022032023013040150320000000
00000000000000.220.320.230.130.041.972.2306.730.010.065.146.4
0.010.070.290.280.240.280.180.20.30.220.350.41.331.140.770.80.910.742.693.094.448.331.461.15.767.76
0.485.386.374.214.036.323.644.848.426.444.3116.1214.2310.5310.525.136.74.866.815.432.4631.2837.7436.417.3112.91
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Burcon NutraScience provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Burcon NutraScience's financial health and stability.

Assets

Burcon NutraScience's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Burcon NutraScience must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Burcon NutraScience after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Burcon NutraScience's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00-2-3-3-2-3-2-3-4-4-6-8-5-5-5-6-6-5-5-4-40-10-25
0000000000000000000000000
0000000000000000000000000
0000000000000000000000000
0000000001124110111001-1419
0000000000000000000000000
0000000000000000000000000
00-1-2-3-2-2-1-2-2-2-3-3-4-4-4-4-4-4-4-4-3-3-5-6
000-1000000000000000000000
000-1,0000000000-2,0000-1,00001,000-1,0001,000000-14,000-2,000-1,000-4,000
00000000000-20-102-11000-14-1-1-4
0000000000000000000000000
0000000000000000002016004
022235036011510607353027500
022234036011510507363132404
----------------------1.00---
0000000000000000000000000
010-102-213-1-19-2-50-3102-1-214-1-6-5
-0.01-0.58-2.02-4.45-3.39-2.19-2.6-1.94-2.52-2.78-3.03-4.09-3.81-4.45-4.85-5.2-4.87-4.94-4.77-4.64-4.17-3.47-3.92-5.96-6.38
0000000000000000000000000

Burcon NutraScience stock margins

The Burcon NutraScience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Burcon NutraScience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Burcon NutraScience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Burcon NutraScience's sales revenue. A higher gross margin percentage indicates that the Burcon NutraScience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Burcon NutraScience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Burcon NutraScience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Burcon NutraScience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Burcon NutraScience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Burcon NutraScience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Burcon NutraScience Margin History

Burcon NutraScience Gross marginBurcon NutraScience Profit marginBurcon NutraScience EBIT marginBurcon NutraScience Profit margin
2026e-752.94 %5.68 %16.21 %
2025e-752.94 %-140.63 %-133.71 %
2024-752.94 %-3,807.21 %-4,038.94 %
2023-752.94 %-2,088.89 %-7,044.44 %
2022-752.94 %-4,329.41 %-6,035.29 %
2021-203.85 %-1,761.54 %-238.46 %
2020-2,733.33 %-12,100 %-15,433.33 %
2019-2,950 %-10,900 %-11,950 %
2018-3,380 %-11,260 %-11,240 %
2017-1,422.22 %-6,355.55 %-6,422.22 %
2016-752.94 %-6,172.73 %-5,972.73 %
2015-752.94 %-6,263.64 %-5,981.82 %
2014-752.94 %-6,944.44 %-6,622.22 %
2013-752.94 %-18,766.67 %-18,500 %
2012-752.94 %0 %0 %
2011-752.94 %0 %0 %
2010-752.94 %0 %0 %
2009-752.94 %0 %0 %
2008-752.94 %0 %0 %
2007-752.94 %0 %0 %
2006-752.94 %0 %0 %
2005-752.94 %0 %0 %

Burcon NutraScience Stock Sales Revenue, EBIT, Earnings per Share

The Burcon NutraScience earnings per share therefore indicates how much revenue Burcon NutraScience has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Burcon NutraScience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Burcon NutraScience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Burcon NutraScience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Burcon NutraScience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Burcon NutraScience Revenue, EBIT and net profit per share

DateBurcon NutraScience Sales per ShareBurcon NutraScience EBIT per shareBurcon NutraScience Earnings per Share
2026e0.06 undefined0 undefined0.01 undefined
2025e0.02 undefined0 undefined-0.03 undefined
20240 undefined-0.06 undefined-0.06 undefined
20230 undefined-0.07 undefined-0.23 undefined
20220 undefined-0.07 undefined-0.09 undefined
20210 undefined-0.04 undefined-0.01 undefined
20200 undefined-0.05 undefined-0.06 undefined
20190 undefined-0.1 undefined-0.11 undefined
20180 undefined-0.15 undefined-0.15 undefined
20170 undefined-0.16 undefined-0.16 undefined
20160 undefined-0.19 undefined-0.18 undefined
20150 undefined-0.21 undefined-0.2 undefined
20140 undefined-0.2 undefined-0.19 undefined
20130 undefined-0.18 undefined-0.18 undefined
20120 undefined-0.2 undefined-0.2 undefined
20110 undefined-0.3 undefined-0.3 undefined
20100 undefined-0.25 undefined-0.25 undefined
20090 undefined-0.19 undefined-0.19 undefined
20080 undefined-0.17 undefined-0.16 undefined
20070 undefined-0.16 undefined-0.15 undefined
20060 undefined-0.14 undefined-0.13 undefined
20050 undefined-0.17 undefined-0.17 undefined

Burcon NutraScience business model

Burcon NutraScience Corp is a Canadian company specializing in the production of plant-based proteins. It was founded in 1998 and is based in Vancouver, British Columbia. The company's business model is based on the research, development, and marketing of innovative plant-based proteins. Burcon operates in two main sectors: the development of proteins from canola oil, known as Clarisoy, and the development of proteins from peas and soybeans. The company has partnerships and intellectual property rights that allow it to produce proteins from various sources. Burcon plans to increase its production of plant-based proteins in the coming years to meet the growing demand for plant-based foods. Burcon NutraScience is one of the most popular companies on Eulerpool.com.

Burcon NutraScience SWOT Analysis

Strengths

1. Strong intellectual property portfolio, including valuable patents and trademarks.

2. Established reputation in the nutraceutical industry, recognized for high-quality products.

3. Strong financial position with steady revenue growth and healthy profit margins.

4. Well-established distribution network, ensuring widespread product availability.

Weaknesses

1. Relatively small scale compared to major competitors, limiting economies of scale.

2. Limited product portfolio, focused primarily on plant-based proteins.

3. Dependency on raw material suppliers for sourcing key ingredients.

4. Vulnerability to regulatory changes impacting the nutraceutical industry.

Opportunities

1. Increasing consumer interest in plant-based diets and sustainable food options.

2. Growing demand for plant-based proteins in the food and beverage industry.

3. Expansion into new markets and regions to capture untapped customer segments.

4. Potential partnerships with major food and beverage companies for product innovation.

Threats

1. Intense competition from larger and more established nutraceutical companies.

2. Volatile commodity prices affecting raw material costs.

3. Regulatory uncertainties and potential legal challenges to intellectual property rights.

4. Economic downturns impacting consumer spending on premium nutraceutical products.

Burcon NutraScience Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Burcon NutraScience historical P/E ratio, EBIT multiple, and P/S ratio

Burcon NutraScience shares outstanding

The number of shares was Burcon NutraScience in 2023 — This indicates how many shares 108.73 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Burcon NutraScience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Burcon NutraScience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Burcon NutraScience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Burcon NutraScience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Burcon NutraScience.

Burcon NutraScience latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240 -0.01  (0 %)2024 Q3
6/30/20240 -0.01  (0 %)2024 Q2
3/31/20240 -0.01  (0 %)2024 Q1
9/30/20230 -0.04  (0 %)2023 Q3
9/30/2021-0.02 -0.01  (51.46 %)2022 Q2
9/30/2016-0.04 -0.04  (-10.8 %)2017 Q2
6/30/2016-0.05 -0.04  (22.33 %)2017 Q1
3/31/2016-0.05 -0.04  (22.33 %)2016 Q4
12/31/2015-0.05 -0.05  (2.91 %)2016 Q3
9/30/2015-0.05 -0.04  (22.33 %)2016 Q2
1
2

Burcon NutraScience shareholders

%
Name
Stocks
Change
Date
17.97959 % Chan (Alan Yiu Lun)25,643,93208/1/2024
5.79834 % Vassallo (John A)8,270,05609/23/2024
2.19436 % Pekar (James Peter)3,129,7673,129,7678/1/2024
1.01818 % Kappel (Peter Henry)1,452,206150,0008/1/2024
0.73588 % Tyrrell (David Lorne John)1,049,56593,0223/12/2024
0.16983 % Lam (Paul Chun-Po)242,22752,8004/10/2024
0.15425 % Quadriga Asset Managers SGIIC, S.A.220,000220,00012/31/2023
0.12982 % Schweizer (Martin Hans)185,1656,8911/31/2024
0.11918 % Keppenne (Benoit)169,98190,0003/12/2024
0.11414 % Fang (Debora S)162,79508/1/2024
1
2
3

Burcon NutraScience Executives and Management Board

Ms. Dorothy Law(49)
Burcon NutraScience Senior Vice President - Legal, Corporate Secretary (since 1998)
Compensation 296,330
Mr. Randy Willardsen
Burcon NutraScience Senior Vice President - Process
Compensation 295,695
Ms. Jade Cheng
Burcon NutraScience Chief Financial Officer, Treasurer (since 2020)
Compensation 269,057
Dr. Martin Schweizer
Burcon NutraScience Vice President - Technical Development
Compensation 247,557
Ms. Jeanne Mccaherty
Burcon NutraScience Independent Director
Compensation 192,360
1
2
3

Burcon NutraScience Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Bunge Stock
Bunge
SupplierCustomer0,120,36-0,26-0,85-0,85-0,29
1

Most common questions regarding Burcon NutraScience

What values and corporate philosophy does Burcon NutraScience represent?

Burcon NutraScience Corp represents a commitment to sustainable and innovative solutions in the field of functional and plant-based proteins. The company's corporate philosophy revolves around enhancing health and wellness through the development of high-quality, plant-based protein ingredients. Burcon NutraScience Corp values integrity, transparency, and scientific excellence in its operations. By continually investing in research and development, the company strives to create valuable and sustainable products that meet the growing demand for plant-based alternatives in the food and beverage industry. With a focus on customer satisfaction and environmental responsibility, Burcon NutraScience Corp is dedicated to delivering cutting-edge protein solutions for a better future.

In which countries and regions is Burcon NutraScience primarily present?

Burcon NutraScience Corp is primarily present in Canada and the United States.

What significant milestones has the company Burcon NutraScience achieved?

Burcon NutraScience Corp has achieved several significant milestones. One notable achievement is the development of its patented technology, which allows the extraction of plant-based proteins with exceptional functional and nutritional properties. Another milestone is the commercial production of CLARISOY™, a highly soluble and clean-tasting soy protein isolate. The company has also formed strategic partnerships with global food manufacturers, enabling the incorporation of Burcon's proteins into various food and beverage products. Additionally, Burcon NutraScience Corp has received regulatory approvals for its novel protein ingredients. These achievements demonstrate the company's commitment to innovative solutions in the plant-based protein industry.

What is the history and background of the company Burcon NutraScience?

Burcon NutraScience Corp, founded in 1998, is a leading Canadian company dedicated to developing functional and sustainable plant proteins. With a strong focus on innovation, Burcon has created an extensive portfolio of novel protein ingredients derived from peas, canola, and hemp. These ingredients possess exceptional nutritional profiles and offer numerous health benefits. Burcon NutraScience Corp has built strategic partnerships with industry leaders, including global food, beverage, and pharmaceutical companies. Leveraging their expertise and cutting-edge technologies, Burcon aims to revolutionize the protein market by delivering sustainable and high-quality plant-based protein solutions. Combining a rich history of innovation and a commitment to sustainable practices, Burcon NutraScience Corp continues to shape the future of the plant-based protein industry.

Who are the main competitors of Burcon NutraScience in the market?

The main competitors of Burcon NutraScience Corp in the market include companies such as Archer Daniels Midland Company, Cargill, Incorporated, and Ingredion Incorporated.

In which industries is Burcon NutraScience primarily active?

Burcon NutraScience Corp is primarily active in the food and beverage industry, specifically in the development and commercialization of plant-based proteins.

What is the business model of Burcon NutraScience?

The business model of Burcon NutraScience Corp revolves around the development, production, and commercialization of plant-based proteins. Being a leader in the field, Burcon NutraScience Corp focuses on creating innovative and sustainable protein solutions that cater to the growing demand for plant-based alternatives in the food and beverage industry. The company utilizes its patented technologies to extract proteins from various plant sources, including canola and peas, offering functional, nutritionally superior, and environmentally friendly protein products. Burcon NutraScience Corp's business model aligns with the shift towards healthier and more sustainable food options, positioning them as a key player in the plant-based protein market.

What is the P/E ratio of Burcon NutraScience 2024?

The Burcon NutraScience P/E ratio is -1.94.

What is the P/S ratio of Burcon NutraScience 2024?

The Burcon NutraScience P/S ratio is 78.16.

What is the Quality Investing of Burcon NutraScience?

The Quality Investing for Burcon NutraScience is 5/10.

What is the revenue of Burcon NutraScience 2024?

The Burcon NutraScience revenue is 184,360 CAD.

How high is the profit of Burcon NutraScience 2024?

The Burcon NutraScience profit is -7.45 M CAD.

What is the business model of Burcon NutraScience

Burcon NutraScience Corp is a Canadian company specializing in the development, sales, and marketing of innovative plant-based proteins and other functional food ingredients. The company was founded in 1998 and is headquartered in Vancouver, British Columbia.

What is the Burcon NutraScience dividend?

Burcon NutraScience pays a dividend of 0 CAD distributed over payouts per year.

How often does Burcon NutraScience pay dividends?

The dividend cannot currently be calculated for Burcon NutraScience or the company does not pay out a dividend.

What is the Burcon NutraScience ISIN?

The ISIN of Burcon NutraScience is CA1208311029.

What is the Burcon NutraScience WKN?

The WKN of Burcon NutraScience is 157793.

What is the Burcon NutraScience ticker?

The ticker of Burcon NutraScience is BU.TO.

How much dividend does Burcon NutraScience pay?

Over the past 12 months, Burcon NutraScience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Burcon NutraScience is expected to pay a dividend of 0 CAD.

What is the dividend yield of Burcon NutraScience?

The current dividend yield of Burcon NutraScience is .

When does Burcon NutraScience pay dividends?

Burcon NutraScience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Burcon NutraScience?

Burcon NutraScience paid dividends every year for the past 0 years.

What is the dividend of Burcon NutraScience?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Burcon NutraScience located?

Burcon NutraScience is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Burcon NutraScience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Burcon NutraScience from 11/5/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did Burcon NutraScience pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of Burcon NutraScience in the year 2023?

In the year 2023, Burcon NutraScience distributed 0 CAD as dividends.

In which currency does Burcon NutraScience pay out the dividend?

The dividends of Burcon NutraScience are distributed in CAD.

All fundamentals about Burcon NutraScience

Our stock analysis for Burcon NutraScience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Burcon NutraScience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.